Srs Capital Advisors, Inc. Maravai Lifesciences Holdings, Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 4,240 shares of MRVI stock, worth $34,132. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,240Holding current value
$34,132% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding MRVI
# of Institutions
221Shares Held
124MCall Options Held
176KPut Options Held
2.2K-
12 West Capital Management LP New York, NY13.2MShares$106 Million9.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$86.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$78.3 Million0.0% of portfolio
-
Braidwell LP Stamford, CT9.02MShares$72.6 Million2.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$48 Million0.02% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $1.06B
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...